37% Of Medicaid Managed Care Plans Cover The Three FDA-Approved Medications For OUD

About 37% of all Medicaid managed care plans cover all three medications for treating opioid use disorder (MOUD) that are approved by the U.S. Food and Drug Administration (FDA)—buprenorphine, extended-release naltrexone, and methadone—according to a recent study. The percentage is much lower than anticipated, as the 2018 SUPPORT Act (Substance Use Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities) includes provisions requiring Medicaid managed care plans to cover all three MOUD for five years, starting October 1, 2020, the study stated.

The analysis was based on coverage policies as of December 2023 . . .